logo

For the Inventor, By the Inventor

Cassina Rizzardi, Italy

Domenico Trizio

USPTO Granted Patents = 11

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 93(Granted Patents)


Location History:

  • Milan, IT (1989)
  • Cassina Rizzardi, IT (1992 - 1995)
  • Cassina Rizzardi Como, IT (1997)

Company Filing History:

goldMedal10 out of 140 
 
Farmitalia Carlo Erba S.r.l.
 patents
silverMedal1 out of 97 
 
Pharmacia & Upjohn S.p.a.
 patents

Years Active: 1989-1997

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5691334 - Pyrrolydenemethyl-derivatives and process for their preparation (1997-11-25),
2. 5436154 - Monoclonal antibodies against human Tumor Necrosis Factor .alpha. (1995-07-25),
3. 5424308 - Condensed pyrazole 3-oxo-propanenitrile derivatives (1995-06-13),
4. 5352676 - Morphalinomethyl-substituted 1-phenyl-indero-[1,2-c]pyrazol-3-yl (1994-10-04),
5. 5260328 - Phenyl-indenopurazol 3-oxo-propanamide derivatives useful in the (1993-11-09),
6. 5206258 - Use of heteroaryl-3-oxo-propanenitrile derivatives in treating clinical (1993-04-27),
7. 5196445 - Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of (1993-03-23),
8. 5166152 - Tricyclic 3-oxo-propanenitrile derivatives (1992-11-24),
9. 4853405 - Condensed pyrazole derivatives, pharmaceutical compositions and use (1989-08-01),
10. 4826837 - Cinnoline-carboxamides and process for their preparation (1989-05-02),
11. 4816467 - Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions (1989-03-28),

Title: **Domenico Trizio: Innovator in Biotechnology**

Introduction

Domenico Trizio is a distinguished inventor based in Cassina Rizzardi, Italy, with a remarkable portfolio of 11 patents. His contributions to the field of biotechnology have made a significant impact, particularly in the development of monoclonal antibodies and their applications in detecting protein levels in clinical samples.

Latest Patents

Among his latest innovations are notable patents such as "Pyrrolydenemethyl-derivatives" and "Monoclonal antibodies against human Tumor Necrosis Factor .alpha." This invention features a monoclonal antibody capable of neutralizing both human TNF .alpha. and TNF .beta., as well as providing a stable hybridoma cell line that secretes this unique antibody. These advancements present not only exciting opportunities for therapeutic applications but also methods for accurately measuring human TNF levels in bodily fluids, which can be crucial for various medical diagnoses.

Career Highlights

Throughout his career, Domenico has contributed his expertise to several esteemed companies, including Farmitalia Carlo Erba S.r.l. and Pharmacia & Upjohn S.p.a. His professional journey showcases a deep commitment to innovation in the pharmaceutical sector and highlights his roles in pivotal research and product development.

Collaborations

In his field, Domenico has had the privilege of working alongside noted professionals such as Gianfederico Doria and Mario Ferrari. Such collaborations have allowed for the cross-pollination of ideas and expertise, further enhancing the potential for successful innovations in biotechnology.

Conclusion

Domenico Trizio's legacy as an inventor is marked by a deep commitment to advancing medical science through innovative solutions. His patents, collaborations, and contributions highlight the crucial role inventors play in the ongoing development of healthcare technologies. As the field continues to evolve, his work remains a pivotal reference point for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…